Thriva gets $1.9 million to use at-home blood tests for health tracking

London-based mail order consumer blood testing startup Thriva has raised $1.9 million (1.5 million pounds) in a round of seed funding, the company announced today. Individual investors include Zoopla CEO Alex Chesterman and TransferWise CEO Taavet Hinrikus and funds investing include Seedcamp, 500 Startups and the London Co-Investment Fund (LCIF).
Source: mobihealthnews - Category: Information Technology Source Type: news